The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 115.00
Ask: 117.00
Change: -2.50 (-2.13%)
Spread: 2.00 (1.739%)
Open: 120.50
High: 120.50
Low: 115.00
Prev. Close: 117.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 2022 trading update

23 Nov 2022 07:00

RNS Number : 2656H
Bakkavor Group PLC
23 November 2022
 

23 November 2022

 

Bakkavor Group plc

Q3 2022 trading update

 

Robust Q3 performance; full year within expectations

Bakkavor Group plc (the "Company") and its subsidiaries ("Bakkavor" or "the Group"), the leading international provider of fresh prepared food ("FPF"), today updates on trading for the 13 weeks to 25 September 2022 ("Q3 2022") and guidance for the full year.

 

 

Q3 2022

 

9 months 2022

£ million 

Reported revenue 

Growth 

Like-for-like1 ('LFL') revenue 

LFL growth 

 

Reported revenue 

Growth 

LFL revenue 

LFL growth 

Group

542.5

15.3%

530.5 

12.7% 

 

1,552.7

12.0%

1,530.7 

10.4% 

UK 

445.3

11.9%

445.3 

11.9% 

 

1,294.8

9.2%

1,294.8 

9.2% 

US 

67.5

46.3%

58.3 

26.3% 

 

184.1

44.5%

167.6 

31.6% 

China 

29.7

12.9%

26.9 

1.5% 

 

73.8

0.7%

68.3 

(7.1%) 

 

Robust Q3 revenue growth in line with expectations; continue to navigate a challenging trading environment

· Robust growth in reported revenue, up 15.3% to £542.5m, with LFL revenue up 12.7%.

· UK LFL revenue growth largely driven by price. Volumes held up through the Summer and, although pressure on household budgets impacted volumes in September, we outperformed the FPF market and gained market share. 

· Strong US revenue momentum reflects sustained demand and price increases also taking effect. Operational performance has, however, remained challenging due to disruption as significant volumes were onboarded.

· Volumes in China have continued to recover, with LFL revenue ahead of FY21, and this has supported some margin improvement.

· Ongoing Group-wide mitigation of inflationary headwinds through price recovery, productivity improvements and tight cost control.

· Retained significant liquidity headroom against core debt facilities. Interest rate swaps provide a good level of protection against rate increases through to March 2024.

FY22 outlook within the range of market expectations2

· The Group has continued to trade in line with market expectations, and preparations for the Christmas period are progressing in line with our plan.

· There has been a recent threat of industrial action at one of our UK sites, and we have now reached an agreement with the offer being recommended by the union to the workforce.

· In the US, a reduction in volume due to a contractual dispute with a customer is expected to impact profits in the remaining weeks of the year.

· As a result, we expect Group adjusted operating profit for FY22 to remain within, but at the lower end of the range of market expectations2.

Clear plans in place to protect profits against sustained headwinds into 2023

· Macro-headwinds will persist through 2023, we are therefore taking decisive action to protect future profits. Our plan is focused on three areas:

1. Leaner organisation structure: new Management Board and leadership structure with renewed focus and purpose; operationally align UK business to two sectors driving further synergies.

2. Clear and focused regional priorities:

UK - leveraging operational scale through footprint rationalisation, with two proposed site closures; collaborating with customers on inflation recovery and value optimisation.

US - a renewed focus on operational performance to support margin improvement.

China - rebuilding volume to leverage our well invested platform for growth.

3. Enhanced focus on managing cash: Reviewing capital plans to target efficiency improvements; remain committed to strategic investments; driving working capital benefits.

· Our plan to protect future profits is expected to deliver savings of £15m in FY23, and £25m on an annualised basis3. Cash costs of implementation are estimated at £20m. These costs, together with asset impairment charges, will be recognised as exceptional costs in FY22, whilst most of the cash outflow will be in FY23.

 

Mike Edwards, CEO, commented:

"We continue to operate in an incredibly challenging environment. Bakkavor has proven itself to be a resilient business effectively navigating the turbulence of recent years. We are now taking further decisive action to ensure we deal with the ongoing headwinds and protect future profits.

"These actions, combined with our strong balance sheet, breadth of capability and products, customer relationships and growing market share, means we are well-placed to deal with the short-term challenges, and deliver our longer-term ambitions for colleagues and stakeholders."

 

1. The Group defines 'like-for-like revenue' as revenue from continuing operations adjusted for the revenue generated from businesses closed or sold in the current and prior year, revenue generated from businesses acquired in the current and prior period, and the effect of foreign currency movements.

2. Based on company compiled consensus ("Consensus") which includes the following institutions; Berenberg, Citi, Goodbody, HSBC, Investec, Kepler, Numis and Peel Hunt. Group adjusted operating profit consensus range for 2022 of £88.6m to £91.7m, with consensus at £90.3m. Last updated on 22 November 2022.

3. Our plan includes the proposal to close two sites, as previously reported on our website on 9 November 2022. Consultations at both sites are underway and therefore no final decisions have been made.

 

ENQUIRIES

Institutional investors and analysts:

Ben Waldron, Chief Financial Officer

Emily Daw, Head of Investor Relations +44 (0) 20 7908 6114

Financial media: bakkavor@mhpgroup.com

Katie Hunt, MHP +44 (0) 20 3128 8794

Rachel Farrington, MHP +44 (0) 20 3128 8613

Oliver Hughes, MHP +44 (0) 20 3128 8622

 

 

About Bakkavor

We are the leading provider of fresh prepared food ("FPF") in the UK, and our presence in the US and China positions the Group well in these, high-growth markets. We leverage our consumer insight and scale to provide innovative food that offers quality, choice, convenience, and freshness. Over 19,000 colleagues operate from 46 sites across our three markets supplying a portfolio of over 3,200 products across meals, pizza & bread, salads and desserts to leading grocery retailers in the UK and US, and international food brands in China.

LEI number: 213800COL7AD54YU9949

Disclaimer - forward-looking statements

This statement, prepared by Bakkavor, may contain forward-looking statements about Bakkavor. These represent expectations for the Group's business, and involve known and unknown risks and uncertainties, many of which are beyond the Group's control. The Group has based these forwardlooking statements on current expectations and projections about future events. These forward-looking statements may generally, but not always, be identified by the use of words such as 'will', 'aims', 'anticipates', 'continue', 'could', 'should', 'expects', 'is expected to', 'may', 'estimates', 'believes', 'intends', 'projects', 'targets', or the negative thereof, or similar expressions.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect the Group's current expectations and assumptions as to such future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by forward-looking statements. There may be risks and uncertainties that the Group is unable to predict at this time or that the Group currently does not expect to have a material adverse effect on its business. You should not place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this announcement. The Group expressly disclaims any obligation to publicly update or review these forward-looking statements other than as required by law. Some numbers and period on period percentages in this statement have been rounded or adjusted in order to ensure consistency with the financial information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBTBFTMTATBPT
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.